| Website | transoral.com |
| Category | BioTech |
| Phone | 510.215.3500 |
| info@transcept.com | |
| Employees | |
| Description | biotechnology company |
| TOTAL | $40M |
| FUNDING TOTAL | $40M |
| Series D, 3/07 New Enterprise Associates New Leaf Venture Partners Montreux Equity Partners InterWest Partners Hamilton BioVentures Vivo Ventures Peninsula Ventures Hercules Technology Growth Capital | $40M |
Transcept Pharmaceuticals, Inc. uses its proprietary delivery system to enhance the penetration of drugs, significantly speeding their onset of action. Transcept is developing rapid-acting versions of several major market pharmaceuticals. Hamilton co-invested in the company’s first institutional round of funding alongside Montreaux Equity Partners, Peninsula Equity Partners and Vivo Ventures. Investors in subsequent financing rounds include these firms, and New Leaf Venture Partners, Interwest Partners and New Enterprise Associates.
